Animal models - What they can tell Us about vascular calcification in CKD

Seminars in Dialysis

Volumn 20, Issue 2, 2007, Pages 110-112

  Massy, Ziad A ^a,b   Slama, Michel ^a,b   Tribouilloy, Christophe ^a,b   Drüeke, Tilman B ^a,c  

^a INSERM   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; CHELATING AGENT; POLYAMINE; SEVELAMER; VITAMIN D;

ANIMAL; ARTICLE; CALCINOSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; DISEASE MODEL; HUMAN; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CALCINOSIS; CARDIOVASCULAR DISEASES; CHELATING AGENTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; POLYAMINES; VITAMIN D;

EID: 33947326916     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00256.x     Document Type: Article

References (20)

1. Jungers P, Khoa TN, Joly D, Choukroun G, Witko-Sarsat V, Massy ZA: Atherosclerotic complications in chronic renal failure: epidemiology and predictive factors. Adv Nephrol Necker Hosp 30:177-199, 2000
2. Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N: Vascular Calcification Work Group. Vascular calcification in chronic kidney disease. Am J Kidney Dis 43:572-579, 2004
3. London GM, Guerin AP, Marchais SJ, Motivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740, 2003
4. Drucke TB, Massy ZA: Advanced oxidation protein products, parathyroid hormone and vascular calcification in uremia. Blood Purif 20:494-497, 2002
5. Massy ZA, Nguyen-Khoa T: Oxidative stress and chronic renal failure: markers and management. J Nephrol 15:336-341, 2002
6. Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drueke TB, Muntzel MS: Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 16:109-116, 2005
7. Davies MR, Lund RJ, Hruska KA: BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 14:1559-1567, 2003
8. Angulo J, Nguyen-Khoa T, Massy ZA, Drueke T. B, Serra J: Morphological quantification of aortic calcification from low magnification images. Image Anal Stereol 22:81-89, 2003
9. Jono S, Nishizawa Y, Shioi A. Morii H: 1, 25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98:1302-1306, 1998
10. Panichi V, De Pietro S, Andreini B, Blanchi AM, Migliori M, Taccola D, Giovannini L, Tetta C, Palla R: Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Kidney Int 54:1463-1469, 1998
11. Krog M, Ejerblad S, Eriksson I, Johansson H: Arterial calcifications in uraemic rats treated with 1-alpha-hydroxycholecalciferol and parathyroidectomy. Scand J Urol Nephrol 18:227-239, 1984
12. Lopez I, Aguilera-Tejero E, Mendoza FJ, Almaden Y, Perez J, Martin D, Rodriguez M: Calcimimetic R-568 decreases extraosscous calcifications in uremie rats treated with calcitriol. J Am Soc Nephrol 17:795-804, 2006
13. Henley C, Colloton M, Cattley RC, Shatzen E, Towler DA, Lacey D, Martin D; 1,25-Dihydroxyvitamin D3 but not cinaealcet HO (Sensipar/M impara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 20:1370-1377, 2005
14. Haffner D, Hocher B, Muller D, Simon K, Konig K, Richter CM, Eggert B, Schwarz J, Godes M, Nissel R, Querfeld U: Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J Hypertens 23:1067-1075, 2005
15. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kid-Key Int 62:245-252, 2002
16. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68:1815-1824, 2005
17. Phan O, Ivanovski O, Nguyen-Khoa T, Mothu N, Angulo J, Westenfeld R, Ketteler M, Meert N, Maizel J, Nikolov IG, Vanholder R, Laeour B, Drueke TB, Massy ZA: Sevelamer prevents uremiaenhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation 112:2875-2882, 2005
18. Mathew S, Tustison KS, Hruska K A: Sevelamer reverses aortic calcification in a model of the metabolic syndrome with chronic kidney disease (Abstract). J Am Soc Nephrol 15:506A, 2004
19. Bro S, Moeller F, Andersen CB, Olgaard K, Nielsen LB: Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. J Am Soc Nephrol 15:1495-1503, 2004
20. Bro S, Borup R, Andersen CB, Moeller F, Olgaard K, Nielsen LB: Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 26:570-575, 2006